Role of host genes in sporadic gastric cancer

Best Practice and Research: Clinical Gastroenterology

Volumn 20, Issue 4, 2006, Pages 675-686

  El Omar, Emad M ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

cytokines; gastric cancer; genetic polymorphisms; Helicobacter pylori; interleukins; single nucleotide polymorphisms; toll like receptors

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 8; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER GENETICS; CANCER IMMUNOLOGY; CANCER RISK; CANCER SUSCEPTIBILITY; CHRONIC GASTRITIS; DEVELOPING COUNTRY; DISEASE SEVERITY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HLA SYSTEM; HUMAN; MALIGNANT TRANSFORMATION; STOMACH CANCER; STOMACH CARCINOGENESIS;

DNA, BACTERIAL; DNA, NEOPLASM; HELICOBACTER PYLORI; HUMANS; POLYMORPHISM, GENETIC; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33748708619     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2006.04.006     Document Type: Article

References (54)

1. Parkin D.M., Bray F., Ferlay J., et al. Global cancer statistics, 2002. CA Cancer J Clin 55 2 (2005) 74-108
2. Suerbaum S., and Michetti P. Helicobacter pylori infection. N Engl J Med 347 15 (2002) 1175-1186
3. Peek Jr. R.M., and Blaser M.J. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2 1 (2002) 28-37
4. El-Omar E.M., Oien K., El Nujumi A., et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 113 1 (1997) 15-24
5. Macarthur M., Hold G.L., and El-Omar E.M. Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am J Physiol Gastrointest Liver Physiol 286 4 (2004) G515-G520
6. El-Omar E.M., Penman I.D., Ardill J.E., et al. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 109 3 (1995) 681-691
7. Hansson L.E., Nyren O., Hsing A.W., et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 335 4 (1996) 242-249
8. Blaser M.J., and Atherton J.C. Helicobacter pylori persistence: biology and disease. J Clin Invest 113 3 (2004) 321-333
9. Israel D.A., and Peek R.M. Pathogenesis of Helicobacter pylori-induced gastric inflammation. Aliment Pharmacol Ther 15 9 (2001) 1271-1290
10. Risch N.J. Searching for genetic determinants in the new millennium. Nature 405 6788 (2000) 847-856
11. Collins F.S., Green E.D., Guttmacher A.E., et al. A vision for the future of genomics research. Nature 422 6934 (2003) 835-847
12. Kuipers E.J., Lundell L., Klinkenberg-Knol E.C., et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 334 16 (1996) 1018-1022
13. Kuipers E.J., Lee A., Klinkenberg-Knol E.C., et al. Review article: the development of atrophic gastritis - Helicobacter pylori and the effects of acid suppressive therapy. Aliment Pharmacol Ther 9 4 (1995) 331-340
14. El-Omar E.M. The importance of interleukin 1beta in Helicobacter pylori associated disease. Gut 48 6 (2001) 743-747
15. El-Omar E.M., Carrington M., Chow W.H., et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404 6776 (2000) 398-402
16. El-Omar E.M., Rabkin C.S., Gammon M.D., et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 124 5 (2003) 1193-1201
17. Ando T., El-Omar E.M., Goto Y., et al. Interleukin 1B proinflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy. Gut 55 2 (2006) 158-164
18. Queiroz D.M., Guerra J.B., Rocha G.A., et al. IL1B and IL1RN polymorphic genes and Helicobacter pylori cagA strains decrease the risk of reflux esophagitis. Gastroenterology 127 1 (2004) 73-79
19. Machado J.C., Pharoah P., Sousa S., et al. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 121 4 (2001) 823-829
20. Figueiredo C., Machado J.C., Pharoah P., et al. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 94 22 (2002) 1680-1687
21. Machado J.C., Figueiredo C., Canedo P., et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 125 2 (2003) 364-371
22. Rad R., Prinz C., Neu B., et al. Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. J Infect Dis 188 2 (2003) 272-281
23. Palli D., Saieva C., Luzzi I., et al. Interleukin-1 gene polymorphisms and gastric cancer risk in a high-risk Italian population. Am J Gastroenterol 100 9 (2005) 1941-1948
24. Furuta T., El-Omar E.M., Xiao F., et al. Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 123 1 (2002) 92-105
25. Zeng Z.R., Hu P.J., Pang R.P., et al. The association of interleukin-1B gene polymorphism and gastric cancers in high and low prevalence regions in China. Gut 52 12 (2003) 1684-1689
26. Garza-Gonzalez E., Bosques-Padilla F.J., El-Omar E., et al. Role of the polymorphic IL-1B, IL-1RN and TNF-A genes in distal gastric cancer in Mexico. Int J Cancer 114 2 (2005) 237-241
27. Warren B.F. Cytokines in the cotton top tamarin model of human ulcerative colitis. Aliment Pharmacol Ther 10 supplement 2 (1996) 45-47
28. Lee K.A., Ki C.S., Kim H.J., et al. Novel interleukin 1beta polymorphism increased the risk of gastric cancer in a Korean population. J Gastroenterol 39 5 (2004) 429-433
29. Chang Y.W., Jang J.Y., Kim N.H., et al. Interleukin-1B (IL-1B) polymorphisms and gastric mucosal levels of IL-1beta cytokine in Korean patients with gastric cancer. Int J Cancer 114 3 (2005) 465-471
30. Yang J., Hu Z., Xu Y., et al. Interleukin-1B gene promoter variants are associated with an increased risk of gastric cancer in a Chinese population. Cancer Lett 215 2 (2004) 191-198
31. Tu S., Cui G., Takaishi S., et al. Overexpression of human interleukin-1 beta in transgenic mice results in spontaneous gastric inflammation and carcinogenesis. Gastroenterology 128 4, supplement 2 (2005) A62 [ref type: abstract]
32. Beales I.L., and Calam J. Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut 42 2 (1998) 227-234
33. Smith M.G., Hold G.L., Rabkin C.S., et al. The IL-8-251 promoter polymorphism is associated with high IL-8 production, severe inflammation and increased risk of pre-malignant changes in H-pylori positive subjects. Gastroenterology 124 4, supplement 2 (2004) A23 [ref type: abstract]
34. Taguchi A., Ohmiya N., Shirai K., et al. Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol Biomarkers Prev 14 11 Pt 1 (2005) 2487-2493
35. Lu W., Pan K., Zhang L., et al. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor {alpha} and risk of gastric cancer in a Chinese population. Carcinogenesis 26 3 (2005) 631-636
36. Lee W.P., Tai D.I., Lan K.H., et al. The -251T allele of the interleukin-8 promoter is associated with increased risk of gastric carcinoma featuring diffuse-type histopathology in Chinese population. Clin Cancer Res 11 18 (2005) 6431-6441
37. Ohyauchi M., Imatani A., Yonechi M., et al. The polymorphism interleukin 8-251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut 54 3 (2005) 330-335
38. Smith M.G., Hold G.L., Rabkin C.S., et al. The interleukin-8-251 promoter polymorphism and risk of gastric cancer in Caucasian and Japanese populations. Gastroenterology 128 4, supplement 2 (2006) A-19 [ref type: abstract]
39. Segal E.D., Lange C., Covacci A., et al. Induction of host signal transduction pathways by Helicobacter pylori. Proc Natl Acad Sci U S A 94 14 (1997) 7595-7599
40. Su B., Ceponis P.J., Lebel S., et al. Helicobacter pylori activates Toll-like receptor 4 expression in gastrointestinal epithelial cells. Infect Immun 71 6 (2003) 3496-3502
41. Pasare C., and Medzhitov R. Toll-like receptors: linking innate and adaptive immunity. Adv Exp Med Biol 560 (2005) 11-18
42. Takeda K., and Akira S. Toll-like receptors in innate immunity. Int Immunol 17 1 (2005) 1-14
43. Arbour N.C., Lorenz E., Schutte B.C., et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25 2 (2000) 187-191
44. Franchimont D., Vermeire S., El Housni H., et al. Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 53 7 (2004) 987-992
45. Lorenz E., Mira J.P., Frees K.L., et al. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med 162 9 (2002) 1028-1032
46. Kiechl S., Lorenz E., Reindl M., et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 347 3 (2002) 185-192
47. Higgins S.C., Lavelle E.C., McCann C., et al. Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology. J Immunol 171 6 (2003) 3119-3127
48. Hold G.L., Smith M.G., McColl K.E., et al. A functional Toll-like receptor 4 polymorphism increases risk of H. pylori-induced premalignant changes. Gastroenterology 124 4 (2003) A18 [ref type: abstract]
49. Hold G.L., Smith M.G., Chow W.H., et al. A functional Toll-like receptor 4 polymorphism increases risk of gastric cancer. Gastroenterology 126 4, supplement 2 (2004) A245 [ref type: abstract]
50. Sanduleanu S., Jonkers D., De Bruine A., et al. Double gastric infection with Helicobacter pylori and non-Helicobacter pylori bacteria during acid-suppressive therapy: increase of pro-inflammatory cytokines and development of atrophic gastritis. Aliment Pharmacol Ther 15 8 (2001) 1163-1175
51. Zavros Y., Rieder G., Ferguson A., et al. Genetic or chemical hypochlorhydria is associated with inflammation that modulates parietal and G-cell populations in mice. Gastroenterology 122 1 (2002) 119-133
52. Lee J.E., Lowy A.M., Thompson W.A., et al. Association of gastric adenocarcinoma with the HLA class II gene DQB10301. Gastroenterology 111 2 (1996) 426-432
53. Azuma T., Ito S., Sato F., et al. The role of the HLA-DQA1 gene in resistance to atrophic gastritis and gastric adenocarcinoma induced by Helicobacter pylori infection. Cancer 82 6 (1998) 1013-1018
54. Magnusson P.K.E., Enroth H., Eriksson I., et al. Gastric Cancer and Human Leukocyte Antigen: Distinct DQ and DR Alleles Are Associated with Development of Gastric Cancer and Infection by Helicobacter pylori. Cancer Res 61 6 (2001) 2684-2689